Molecular, genetic and epigenetic pathways of peroxynitrite-induced cellular toxicity

Interdisciplinary Toxicology

Volumn 2, Issue 4, 2009, Pages 219-228

  Korkmaz, Ahmet ^a   Oter, Sukru ^a   Seyrek, Melik ^a   Topal, Turgut ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

antioxidants; cytokines; epigenetic; nitrosative stress; oxidative stress; peroxynitrite

Indexed keywords

EID: 80054111599     PISSN: 13376853     EISSN: 13379569     Source Type: Journal    
DOI: 10.2478/v10102-009-0020-4     Document Type: Article

References (24)

1. Adcock IM, Ito K, Barnes PJ. (2004). Glucocorticoids: effects on gene transcription. Proc Am Thorac Soc 1: 247-54.
2. Aitio ML. (2006). N-acetylcysteine-passe-partout or much ado about nothing? Br J Clin Pharmacol 61: 5-15.
3. Alvarez B, Radi R. (2001). Peroxynitrite decay in the presence of hydrogen peroxide, mannitol and ethanol: a reappraisal. Free Radic Res 34: 467-75.
4. Alvarez B, Radi R. (2003). Peroxynitrite reactivity with amino acids and proteins. Amino Acids 25:: 295-311.
5. Ascherio A, Rimm EB, Hernan MA, Giovannucci E, Kawachi I, Stampfer MJ, Willett WC. (1999). Relation of consumption of vitamin E, vitamin C, and carotenoids to risk for stroke among men in the United States. Ann Intern Med 130: 963-70.
6. Barnes PJ. (2006). How corticosteroids control inflammation: Quintiles Prize Lecture 2005. Br J Pharmacol 148: 245-54.
7. Barnes PJ, Ito K, Adcock IM. (2004). Corticosteroid resistance in chronic obstructive pulmonary disease: inactivation of histone deacetylase. Lancet 363: 731-3.
8. Beckman JS, Koppenol WH. (1996). Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol 271: C1424-37.
9. Bjelakovic G, Nikolova D, Gluud LL, Simonetti RG, Gluud C. (2007). Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis. Jama 297: 842-57.
10. Bjelakovic G, Nikolova D, Simonetti RG, Gluud C. (2004). Antioxidant supplements for prevention of gastrointestinal cancers: a systematic review and meta-analysis. Lancet 364: 1219-28.
11. Black PN, Morgan-Day A, McMillan TE, Poole PJ, Young RP. (2004). Randomised, controlled trial of N-acetylcysteine for treatment of acute exacerbations of chronic obstructive pulmonary disease [ISRCTN21676344]. BMC Pulm Med 4: 13. Boman G, Backer U, Larsson S, Melander B, Wahlander L. (1983). Oral acetylcysteine reduces exacerbation rate in chronic bronchitis: report of a trial organized by the Swedish Society for Pulmonary Diseases. Eur J Respir Dis 64: 405-15.
12. Bombail V, Moggs JG, Orphanides G. (2004). Perturbation of epigenetic status by toxicants. Toxicol Lett 149: 51-8.
13. Campbell KJ, Rocha S, Perkins ND. (2004). Active repression of antiapoptotic gene expression by RelA(p65) NF-kappa B. Mol Cell 13: 853-65.
14. Ceriello A. (2006). Controlling oxidative stress as a novel molecular approach to protecting the vascular wall in diabetes. Curr Opin Lipidol 17: 510-8.
15. Chaturvedi N, Sjolie AK, Stephenson JM, Abrahamian H, Keipes M, Castellarin A, Rogulja-Pepeonik Z, Fuller JH. (1998). Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes. The EUCLID Study Group. EURODIAB Controlled Trial of Lisinopril in Insulin-Dependent Diabetes Mellitus. Lancet 351: 28-31.
16. Chen LF, Greene WC. (2003). Regulation of distinct biological activities of the NF-kappaB transcription factor complex by acetylation. J Mol Med 81: 549-57.
17. Chien YH, Bau DT, Jan KY. (2004). Nitric oxide inhibits DNA-adduct excision in nucleotide excision repair. Free Radic Biol Med 36: 1011-7.
18. Cooke CL, Davidge ST. (2002). Peroxynitrite increases iNOS through NF-kappaB and decreases prostacyclin synthase in endothelial cells. Am J Physiol Cell Physiol 282: C395-402.
19. Culpitt SV, Maziak W, Loukidis S, Nightingale JA, Matthews JL, Barnes PJ. (1999). Effect of high dose inhaled steroid on cells, cytokines, and proteases in induced sputum in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 160: 1635-9.
20. Dai Y, Rahmani M, Grant S. (2003). An intact NF-kappaB pathway is required for histone deacetylase inhibitor-induced G1 arrest and maturation in U937 human myeloid leukemia cells. Cell Cycle 2: 467-72.
21. de Grey AD. (2006). Free radicals in aging: causal complexity and its biomedical implications. Free Radic Res 40: 1244-9.
22. de la Lastra CA, Villegas I, Sanchez-Fidalgo S. (2007). Poly(ADP-ribose) polymerase inhibitors: new pharmacological functions and potential clinical implications. Curr Pharm Des 13: 933-62.
23. Decramer M, Rutten-van Molken M, Dekhuijzen PN, Troosters T, van Herwaarden C, Pellegrino R, van Schayck CP, Olivieri D, Del Donno M, De Backer W et al. (2005). Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS): a randomised placebo-controlled trial. Lancet 365: 1552-60.
24. Dedon PC, Tannenbaum SR. (2004). Reactive nitrogen species in the chemical biology of inflammation. Arch Biochem Biophys 423: 12-22.